TheraBest Pipeline
| Technology | Product | Indication | Partnership | Discovery | Pre-Clinical | Clinical |
|---|---|---|---|---|---|---|
| EiNK | TB-100 | Solid tumor |
|
|||
| EiNK (αMUC1 CAR) |
TB-201 | TNBC, Solid tumor |
|
|
||
| EiNK (αCD19 CAR) |
TB-219 | Lymphoid tumor |
|
|||
| EiNK | TB-200 | Alzheimer’s Disease |
|
|||
| EiNK, ROD |
TB-200 ROD-02 |
Pancreatic cancer |
|
|||
| EiNK (undisclosed), MNKE |
TB-301 TNKE-201 |
Solid tumor |
|
|
||
| RNK (aMUC1 CAR) |
TB-101 | TNBC, Solid tumor |
|
|
||
| EBI-H |
EBI-01 |
Atopic dermatitis |
Phase 2a |
|||
|
EBI-02 |
Liver Cirrhosis |
Phase 1 |
* EBI-H : Ex vivo Boosted Immune cell - Human